These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37829941)

  • 41. Amyloid Cardiopathy and Aortic Stenosis.
    Gherasim L
    Maedica (Bucur); 2021 Sep; 16(3):473-481. PubMed ID: 34925605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.
    Scully PR; Patel KP; Treibel TA; Thornton GD; Hughes RK; Chadalavada S; Katsoulis M; Hartman N; Fontana M; Pugliese F; Sabharwal N; Newton JD; Kelion A; Ozkor M; Kennon S; Mullen M; Lloyd G; Menezes LJ; Hawkins PN; Moon JC
    Eur Heart J; 2020 Aug; 41(29):2759-2767. PubMed ID: 32267922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study.
    Fontana M; Banypersad SM; Treibel TA; Abdel-Gadir A; Maestrini V; Lane T; Gilbertson JA; Hutt DF; Lachmann HJ; Whelan CJ; Wechalekar AD; Herrey AS; Gillmore JD; Hawkins PN; Moon JC
    Radiology; 2015 Nov; 277(2):388-97. PubMed ID: 25997029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-cardiac biopsy sites with high frequency of transthyretin amyloidosis.
    Dasari S; Dispenzieri A; Mansour S; Muppa P; Kurtin PJ; Theis JD; Vrana JA; Grogan M; Kourelis T; Gertz MA; McPhail ED
    ESC Heart Fail; 2021 Feb; 8(1):750-755. PubMed ID: 33277823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
    Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
    Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
    Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S
    Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Short and Mid-Term Mortality and Morbidity in Patients With Severe Aortic Stenosis (Intermediate/High Risk) Who Underwent Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement.
    Yesiltas MA; Haberal İ; Kuserli Y; Yildiz A; Koyuncu AO; Özsoy SD
    Heart Surg Forum; 2020 Apr; 23(2):E212-E220. PubMed ID: 32364917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology and clinical manifestations of cardiac amyloidosis.
    Bajwa F; O'Connor R; Ananthasubramaniam K
    Heart Fail Rev; 2022 Sep; 27(5):1471-1484. PubMed ID: 34694575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant.
    Ono R; Takahashi H; Sato T; Yamazaki T; Hori Y; Fukushima K
    J Cardiol Cases; 2020 Nov; 22(5):221-225. PubMed ID: 33133314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A descriptive study of transthyretin amyloidosis in a tertiary hospital without a referral unit.
    Bueno Juana E; Gracia Gutiérrez A; Melero Polo J; Roteta Unceta-Barrenechea A; Andrés Gracia A; Lahuerta Pueyo C; Menao Guillén S; Revilla Martí P; Aibar Arregui MÁ
    Rev Clin Esp (Barc); 2022 Mar; 222(3):161-168. PubMed ID: 34563487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
    Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
    JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.
    Gonzalez-Lopez E; Escobar-Lopez L; Obici L; Saturi G; Bezard M; Saith SE; AbouEzzeddine OF; Mussinelli R; Gagliardi C; Kharoubi M; Griffin JM; Dispenzieri A; Vilches S; Perlini S; Longhi S; Oghina S; Rivas A; Grogan M; Maurer MS; Damy T; Palladini G; Rapezzi C; Garcia-Pavia P
    JACC CardioOncol; 2022 Nov; 4(4):442-454. PubMed ID: 36444226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Socioeconomic and Racial Disparities: a Case-Control Study of Patients Receiving Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis.
    Sleder A; Tackett S; Cerasale M; Mittal C; Isseh I; Radjef R; Taylor A; Farha R; Lupak O; Larkin D; Lamerato L; Divine G; Wisdom K; Baker-Genaw K; O'Neill W
    J Racial Ethn Health Disparities; 2017 Dec; 4(6):1189-1194. PubMed ID: 28039604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CMR-based differentiation of AL and ATTR cardiac amyloidosis.
    Dungu JN; Valencia O; Pinney JH; Gibbs SD; Rowczenio D; Gilbertson JA; Lachmann HJ; Wechalekar A; Gillmore JD; Whelan CJ; Hawkins PN; Anderson LJ
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):133-42. PubMed ID: 24412186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aortic valve replacement in patients with amyloidosis.
    Java AP; Greason KL; Dispenzieri A; Grogan M; King KS; Maleszewski JJ; Daly RC; Eleid MF; Pochettino A; Schaff HV
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):98-103. PubMed ID: 29397971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.
    Ungericht M; Wanschitz J; Kroiss AS; Röcken C; Schuetz T; Messner M; Zaruba MM; Loescher WN; Poelzl G
    J Nucl Cardiol; 2023 Aug; 30(4):1420-1426. PubMed ID: 35581484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of cardiac
    Kadoya Y; Zen K; Tamaki N; Yashige M; Takamatsu K; Ito N; Kuwabara K; Yamano M; Yamano T; Nakamura T; Yaku H; Matoba S
    ESC Heart Fail; 2021 Apr; 8(2):1106-1116. PubMed ID: 33400391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Structural and Functional Cardiac Changes With Transcatheter Aortic Valve Replacement Outcomes in Patients With Aortic Stenosis.
    Fukui M; Gupta A; Abdelkarim I; Sharbaugh MS; Althouse AD; Elzomor H; Mulukutla S; Lee JS; Schindler JT; Gleason TG; Cavalcante JL
    JAMA Cardiol; 2019 Mar; 4(3):215-222. PubMed ID: 30725109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between spinal stenosis and wild-type ATTR amyloidosis.
    Godara A; Riesenburger RI; Zhang DX; Varga C; Fogaren T; Siddiqui NS; Yu A; Wang A; Mastroianni M; Dowd R; Nail TJ; McPhail ED; Kurtin PJ; Theis JD; Toskic D; Arkun K; Pilichowska M; Kryzanski J; Patel AR; Comenzo R
    Amyloid; 2021 Dec; 28(4):226-233. PubMed ID: 34263670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.